Back to search results

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Colorectal Cancer · Cholangiocarcinoma · Appendiceal Adenocarcinoma · Pancreatic Adenocarcinoma · Gastric Adenocarcinoma · Endometrial Adenocarcinoma · Triple Negative Breast Cancer · Ovarian Cancer · Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope, Duarte, California, United States

  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, United States

  • Florida Cancer Specialists & Research Institute, Sarasota, Florida, United States

    Contact: Study coordinator (Carly Taylor) · ctaylor@flcancer.com

  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (University of Michigan Cancer AnswerLine) · CancerAnswerLine@med.umich.edu · 800-865-1125

  • Duke Cancer Institute, Durham, North Carolina, United States

    Contact: Study coordinator (Sabina Wlazlo Cascalheiro) · sabina.wlazlo@duke.edu · 919-613-4812

  • Carolina BioOncology Institute, Huntersville, North Carolina, United States

    Contact: Study coordinator (Hannah Wall) · hwall@carolinabiooncology.org · 980-441-1148
    Study coordinator · 704-947-6599

  • Medical University of South Carolina, Charleston, South Carolina, United States

  • Mary Crowley Cancer Research, Dallas, Texas, United States

    Contact: Study coordinator (Department Contact) · referral@marycrowley.org

  • NEXT Oncology- San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Jordan Georg) · jgeorg@nextoncology.com · 210-580-9521
Study leads

  • Sanjay Aggarwal, MD

    Study Chair

    Apollo Therapeutics Ltd

View source on ClinicalTrials.gov(opens in a new tab)